RARA CRAFT DATABASE for FDA Medical Devices
510(k)K223713

FDA DEVICE FACTS

Powder Free Nitrile Examination Glove (Grey) Tested for Use with Chemotherapy Drugs and Fentanyl Citrate

Better Care Plastic Technology Co., Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEAugust 7, 2023PRODUCT CODELZA

Indications for use

The glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. Gloves have been tested for use with chemotherapy drugs and Fentanyl Citrate. Chemotherapy Drug and Concentration Minimum Breakthrough Detection Time (Minutes) Arsenic Trioxide (1 mg/ml) >240 Azacitidine (25 mg/ml) >240 Bendamustine HCL (5 mg/ml) >240 Bleomycin sulfate (15 mg/ml) >240 Bortezomib (1 mg/ml) >240 Busulfan (6 mg/ml) >240 Carboplatin (10 mg/ml) >240 Carfilzomib (2 mg/ml) >240 Carmustine (3.3 mg/ml) 13.9 Cetuximab (2 mg/ml) >240 Cisplatin (1 mg/ml) >240 Cyclophosphamide (20 mg/ml) >240 Cytarabine (Cytosine) (100 mg/ml) >240 Cytovene (10 mg/ml) >240 Dacarbazine (DTIC) (10 mg/ml) >240 Daunorubicin HCL (5 mg/ml) >240 Decitabine (5-Aza-2’-deoxycytidine) (5 mg/ml) >240 Docetaxel (10 mg/ml) >240 Doxorubicin Hydrochloride (2 mg/ml) >240 Epirubicin HCL(Ellence) (2 mg/ml) >240 Eribulin Mesylate (0.5 mg/ml) >240 Etoposide (Toposar) (20 mg/ml) >240 Fludarabine (25 mg/ml) >240 5-Fluorouracil (50 mg/ml) >240 Fulvestrant (50 mg/ml) >240 Gemcitabine (38 mg/ml) >240 Idarubicin (1.0 mg/ml) >240 Ifosfamide (50 mg/ml) >240 Irinotecan HCL (20 mg/ml) >240 Mechlorethamine HCL (1 mg/ml) >240 Melphalan (5 mg/ml) >240 Methotrexate (25 mg/ml) >240 Mitomycin-C (0.5 mg/ml) >240 Mitoxantrone (2 mg/ml) >240 Oxaliplatin (2 mg/ml) >240 Paclitaxel (6 mg/ml) >240 Paraplatin (10 mg/ml) >240 Pemetrexed (25 mg/ml) >240 Pertuzumab (30 mg/ml) >240 Raltitrexed monohydrate (0.5 mg/ml) >240 Retrovir (10 mg/ml) >240 Rituximab (10 mg/ml) >240 Temsirolimus (25 mg/ml) >240 Thiotepa (10 mg/ml) 44.4 Topotecan HCL (1 mg/ml) >240 Trastuzumab (21 mg/ml) >240 Trisenox (1 mg/ml) >240 Vinblastine (1 mg/ml) >240 Vincrinstine Sulfate (1 mg/ml) >240 Vinorelbine (10 mg/ml) >240 Zoledronic Acid (0.8 mg/ml) >240 Fentanyl Citrate and Concentration Minimum Breakthrough Detection Time (Minutes) Fentanyl Citrate Injection (100mcg/2mL) >240 Simulated Gastric Acid Fluid/Fentanyl Citrate Injection Mix 50/50 Solution >240 *Please note that the following drugs have extremely low permeation times: Carmustine: 13.9 minutes, Thio Tepa: 44.4 minutes Warning: Do not use with Carmustine and Thio Tepa.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 18, 2026